aTyr Pharma, Inc. (ATYR)

aTyr Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-53.93	-50.39	-45.34	-33.77	-16.22	-23.6
Depreciation & Amortization	2.76	2.74	1.7	1.3	1.27	1.37
Share-Based Compensation	2.72	2.6	2.15	1.61	1.47	1.78
Other Operating Activities	-6.56	11.83	-0.4	-2.23	-1.81	0.44
Operating Cash Flow	-55.01	-33.22	-41.89	-33.08	-15.3	-20.01
Capital Expenditures	-2.97	-4.2	-1.46	-0.14	-0.18	-0.03
Change in Investments	19.66	-15.93	48.71	-91.42	7.08	4.95
Investing Cash Flow	16.69	-20.13	47.25	-91.57	6.9	4.93
Share Issuance / Repurchase	24.91	66.62	5.52	110.03	25.23	9.34
Debt Issued / Paid	-0.45	-0.39	-0.07	0	-9.08	-8
Financing Cash Flow	24.46	66.23	5.45	110.03	16.14	1.34
Net Cash Flow	-13.86	12.88	10.81	-14.62	7.74	-13.75
Free Cash Flow	-57.98	-37.42	-43.35	-33.22	-15.49	-20.04
Free Cash Flow Margin	-9860.88%	-10600.85%	-417.37%	-	-148.11%	-4749.05%
Free Cash Flow Per Share	-0.88	-0.70	-1.52	-1.74	-1.69	-5.97

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).